Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parkinson's Disease: PET Scan and Evaluation of Memantine's Pharmacological Effect
2004-004139-74Phase 2Completed
- Sponsor
- Neurologisk afdeling F
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of memantine in Parkinson's disease (PD), sponsored by Neurologisk afdeling F. Primary endpoints: Changes in brain PET tracer signals and Change in UPDRS score at 6 weeks. Started Mar 2005; status: completed.
02
Drugs
memantine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2004-004139-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004139-74.